A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine

A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine

ObjectiveThis study aimed to explore both impairments in attention function in patients with major depressive disorder (MDD) and the efficacy of escitalopram monotherapy or combination therapy with agomelatine.MethodsA total of 54 patients with MDD and 46 healthy controls (HCs) were included. Patien...

Full description

Bibliographic Details
Main Authors: Zhe Li, Ting-Ting Wu, Yi-Ting Xiong, Xin-Yang Zhang, Yan-Ping Bao, Li-Bo Guo, Bao-Jie Han, Su-Xia Li, Yu-Feng Wang, Lin Lu, Xue-Qin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Psychiatry
Subjects:
major depressive disorder
attentional networks test
escitalopram
agomelatine
cognitive function
efficiency
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1188175/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1188175/full

Similar Items